期刊文献+

福辛普利和缬沙坦对自发性高血压模型鼠肾损害中的作用 被引量:2

The effects of fosinopril and valsartan on renal injury in spontaneously hypertensive rats
原文传递
导出
摘要 目的探讨福辛普利(Fosinopril)和缬沙坦(Valsartan)对自发性高血压模型鼠肾损害中的作用。方法 20只22周龄雄性SHR,随机分为高血压组(SHR组)、福辛普利组(Fos组)、缬沙坦组(Val组)和福辛普利+缬沙坦组(Fos+Val组),22周龄雄性Wistar-Kyoto大鼠(WKY组)5只为对照组。检测各组大鼠体重,尾动脉血压,24h尿蛋白定量,尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG酶),左肾/体重比值和血肌酐。HE及Masson染色,显微镜下观察肾脏病理改变。结果实验第8周(30周龄),SHR组收缩压明显高于WKY组,Fos组,Val组及Fos+Val组(P均<0.05),而Fos组,Val组及Fos+Val组收缩压与WKY组比较无统计学差异(P>0.05);Fos组,Val组及Fos+Val组大鼠血肌酐和尿NAG酶明显低于SHR组(P均<0.05),而实验前与实验第8周大鼠蛋白尿排泄量差值(△Upro)均高于SHR组(P<0.05)。SHR组大鼠肾脏出现高血压肾脏损害的病理特征,胶原沉积增多,经Fos和/或Val干预后,高血压引起的肾脏改变明显改善。结论福辛普利和缬沙坦均有保护肾功能、延缓高血压导致肾间质纤维化的作用,但两者联合应用较单一用药在自发性高血压模型鼠中并不产生更大的降低尿蛋白和肾脏保护作用。 Aim To investigate the effects of fosinopril and valsartan on renal injury in spontaneously hypertensive rats. Methods Twenty 22 week-old male SHRs rats were randomly divided into four groups each consisted of five: hypertensive (SHR) group,Fos group,Val group and Fos+Val group; five 22 week-old male Wistar-Kyoto rats (WKY) as the control group. After 8 weeks,the body weigh,cuff-tail blood pressure,24 hours urinary protein (Upro) ,left renal weigh/body weigh ratio,urinary N-acetyl-13-D-glucosaminidase (NAGase) and serum creatinine (Scr) were measured; the pathological changes were viewed under light microscopy by HE and Masson. Results The blood pressure of rats in SHR group was significantly higher than those of the other four groups (P〈0.05),while there was not significantly different in the WKY group,Fos group ,Val group and Fos+Val group (P〉0.05); the levels of Scr and urinary NAGase were lower,and the contrast of 24h Upro in pre- and post-experiment was significant in Fos grpup, Val group and Fos+Val group as compared to SHR group (all P〈0.05). In morphology,a typical pathological feature of hypertensive renal injure,and the increased collagen deposited in renal interstitial area,were observed in the renal of SHR group as compared to the control; but the hypertensive renal injury was ameliorated in Fos group,Val group and Fos+Val group. Conclusions Both of fosinopril and valsartan possess effect on the protection of the kidney and retarding renal interstitial fibrosis induced by hypertension, while the effect of combination of fosinopril and valsattan is not more effective than using fosinopril or valsartan alone.
出处 《中国热带医学》 CAS 2010年第6期724-725,765,共3页 China Tropical Medicine
基金 海南省卫生厅科学研究基金资助
关键词 福辛普利 缬沙坦 高血压 肾纤雏化 Fosinopril Valsartan Hypertension Renal interstitial fibrosis
  • 相关文献

共引文献2

同被引文献37

  • 1赵爱青,马存根,赵森.大鼠肾组织中组织型转谷氨酰胺酶和结缔组织生长因子表达的研究[J].山西医药杂志,2007,36(7):583-585. 被引量:2
  • 2周巧玲,林书典,彭卫生,敖翔,武蓉,成小苗,汤天凤.缬沙坦对血管紧张素Ⅱ抑制klotho基因表达的影响[J].肾脏病与透析肾移植杂志,2007,16(4):336-339. 被引量:13
  • 3Meng X M,Nikolic-Paterson D J,Lan H Y.Inflammatory processes in renal fibrosis[J].Nat Rev Nephrol,2014,10(9):493.
  • 4Leung K C,Tonelli M,James M T.Chronic kidney disease following acute kidney injury-risk and outcomes[J].Nat Rev Nephrol,2013,9(2):77.
  • 5Lawson J,Elliott J,Wheeler-Jones C,et al.Renal fibrosis in feline chronic kidney disease:Known mediators and mechanisms of injury[J].Vet J,2014,Epub ahead of print.
  • 6Eddy A A.Overview of the cellular and molecular basis of kidney fibrosis[J].Kidney Int Suppl(2011),2014,4(1):2.
  • 7Chen W C,Lin H H,Tang M J.Regulation of proximal tubular cell differentiation and proliferation in primary culture by matrix stiffness and ECM components[J].Am J Physiol Renal Physiol,2014,307(6):F695.
  • 8Liu Y.Epithelial to mesenchymal transition in renal fibrogenesis:pathologic significance,molecular mechanism,and therapeutic intervention[J].J Am Soc Nephrol,2004,15(1):1.
  • 9Yang L,Humphreys B D,Bonventre J V.Pathophysiology of acute kidney injury to chronic kidney disease:maladaptive repair[J].Contrib Nephrol,2011,174:149.
  • 10Bai Y,Lu H,Wu C,et al.Resveratrol inhibits epithelialmesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway[J].Biochem Pharmacol,2014,92(3):484.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部